Central Regional Pathology Laboratories PA

Central Regional Pathology Laboratories PA was paid $497K by Medicaid between Jan 2018 and Nov 2024, across 11 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 68% of everything it billed.

33Billing provider infoCENTRAL REGIONAL PATHOLOGY LABORATORIES PA
MAPLEWOOD, MN 55109

33aNPI1609827484assigned 05/15/2006

33bProvider typeAnatomic Pathology & Clinical Pathology Physician

28Total paid$497K

24GClaims10,137

24DCodes billed11

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in Minnesota

Rank by total paid#3 of 13

Median peer was paid$18K

This provider vs. median28×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	2,707	$42K
2019	2,501	$145K
2020	1,566	$91K
2021	1,384	$68K
2022	444	$32K
2023	982	$71K
2024incomplete	553	$49K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
88305	Level IV - Surgical pathology, gross and microscopic examination	68%	5,781	5,311	$337K
88307		20%	984	923	$99K
88304		5.6%	1,176	1,114	$28K
88342		5.1%	599	549	$25K
85060		<1%	260	238	$4K
G0124	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician	<1%	88	84	$2K
83020		<1%	145	125	$1K
84165		<1%	39	37	$448.27
99000		<1%	1,039	956	$314.16
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	13	12	$165.46
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	13	12	$50.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLEMIEUX, JAMIE (BUSINESS OFFICE MANAGER)